BORTEZOMIB D-MANNITOL
ID: ALA5315122
Chembl Id: CHEMBL5315122
Max Phase: Approved
First Approval: 2015
Molecular Formula: C25H35BN4O8
Molecular Weight: 530.39
Molecule Type: Small molecule
Associated Items:
ID: ALA5315122
Chembl Id: CHEMBL5315122
Max Phase: Approved
First Approval: 2015
Molecular Formula: C25H35BN4O8
Molecular Weight: 530.39
Molecule Type: Small molecule
Associated Items:
Synonyms: Bortezomib d-mannitol ester
Trade Names(1): Bortezomib accord
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B1O[C@H]([C@H](O)CO)[C@@H]([C@H](O)CO)O1
Standard InChI: InChI=1S/C25H35BN4O8/c1-15(2)10-21(26-37-22(19(33)13-31)23(38-26)20(34)14-32)30-24(35)17(11-16-6-4-3-5-7-16)29-25(36)18-12-27-8-9-28-18/h3-9,12,15,17,19-23,31-34H,10-11,13-14H2,1-2H3,(H,29,36)(H,30,35)/t17-,19+,20+,21-,22+,23+/m0/s1
Standard InChI Key: QDMRNLRJDHCHLB-DNNBANOASA-N
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 530.39 | Molecular Weight (Monoisotopic): 530.2548 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. European Medicines Agency, |
Source(1):